NYSE$DVA

DaVita HealthCare Partners Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

DaVita reported strong clinical outcomes and financial results due to focus on innovation and operational improvements.

DaVita Inc. announced its Q2 2023 financial results, with consolidated revenues of $3.0 billion. The company reported an operating income of $405 million and a diluted EPS of $1.91. Operating cash flow stood at $450 million, while free cash flow reached $260 million.

  • Consolidated revenues were $3.0 billion.
  • Operating income was $405 million and adjusted operating income was $432 million.
  • Diluted earnings per share was $1.91 and adjusted diluted earnings per share was $2.08.
  • Operating cash flow was $450 million and free cash flow was $260 million.

Headline financials

Total Revenue

$3B

Previous: $2.93B+2.5%
EPS (adj)

$2.08

Previous: $2.30-9.6%
U.S. Dialysis Treatments

7.2M

Previous: 7.3M-0.5%
U.S. Dialysis Treatment Days

78

No prior period
U.S. Dialysis Avg Treatments per Day

92.7K

Previous: 93.2K-0.5%
U.S. Dialysis Avg Revenue per Treatment

$376.73

Previous: $365.54+3.1%
Capital Expenditures

-$272M

Previous: -$265M-2.5%
Free Cash Flow

-$93.5M

Previous: -$40.7M-130.0%
Net Income

$179M

Previous: $225M-20.5%
Operating Income

$405M

Previous: $433M-6.3%
Gross Profit

$3B

Previous: $2.93B+2.5%
Cash & Equivalents

$327M

Previous: $263M+24.7%
Total Assets

$17B

Previous: $17.1B-0.8%
Stock-Based Comp

$29.8M

Previous: $25.2M+18.3%

Revenue & EPS history

DaVita · Revenue · Quarterly

$3B

Q2 2023+2.5%vs Q2 2022
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

DaVita · $3.02B total across 3 segments · Q2 2023

  • U.S. Dialysis Patient Services
    $2.73B+2.6%
  • International Dialysis Patient Service
    $190M+8.6%
  • Integrated Kidney Care
    $94M-8.7%

Forward guidance

DaVita provided its 2023 outlook, expecting adjusted operating income between $1.565 billion and $1.675 billion, adjusted diluted net income per share attributable to DaVita Inc. between $7.00 and $7.80, and free cash flow between $850 million and $1.1 billion.

Tailwinds

  • Adjusted operating income between $1,565 million and $1,675 million.
  • Adjusted diluted net income per share attributable to DaVita Inc. between $7.00 and $7.80.
  • Free cash flow between $850 million and $1,100 million.

Headwinds

  • The forward-looking measures and the underlying assumptions involve significant known and unknown risks and uncertainties.
  • Actual results may vary materially from these forward-looking measures.
  • The widespread impact of the COVID-19 pandemic continues to generate significant risk and uncertainty.
  • Future results could vary materially from the guidance provided.
  • Guidance excludes certain items, including capacity closure charges, severance costs and foreign currency fluctuations, which may be significant.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

+0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+1.6%

Avg return

30 days after

54%

39 / 72 earnings

Positive

+14.7%

Q3 2019

Best reaction

-24.5%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.6%+22.2%+22.4%
Q4 2025+11.0%+26.7%+34.9%
Q3 2025-6.0%-5.2%-5.4%
Q1 2025-0.2%+0.7%-4.9%
Q4 2024-11.1%-12.5%-19.0%
Q3 2024-10.1%-9.8%+5.5%
Q2 2024-1.1%+3.6%+9.8%
Q1 2024-3.8%-1.5%+5.3%
Q4 2023+8.0%+6.9%+19.0%
Q3 2023+7.4%+5.1%+33.9%
Q2 2023+6.7%+8.6%+1.0%
Q1 2023+13.8%+5.9%+13.7%
Q4 2022-0.3%-0.3%-8.4%
Q3 2022-24.5%-27.9%-23.6%
Q2 2022+2.7%+1.8%+1.3%
Q1 2022-7.1%-5.0%-12.7%
Q4 2021-1.2%+3.5%-2.6%
Q3 2021-6.9%-6.2%-12.3%
Q2 2021+10.2%+9.7%+10.0%
Q1 2021+2.8%+8.9%+6.0%
Q4 2020-7.4%-8.1%-4.4%
Q3 2020-0.0%+7.7%+27.4%
Q2 2020-4.3%-8.5%-4.8%
Q1 2020+9.6%+7.5%+9.7%
Q4 2019+8.8%+5.7%-8.0%
Q3 2019+14.7%+13.6%+17.9%
Q2 2019+0.4%-1.5%-5.8%
Q1 2019-10.4%-9.8%-19.4%
Q4 2018+1.3%+3.0%-6.7%
Q3 2018+1.3%-1.5%-14.9%
Q2 2018+5.4%+3.9%-1.4%
Q1 2018+4.7%+1.2%+5.9%
Q4 2017+1.8%+0.3%-5.4%
Q3 2017-8.5%-7.4%+13.0%
Q2 2017-9.8%-10.9%-9.6%
Q1 2017-3.8%-5.3%-2.4%
Q4 2016+3.2%+6.2%+4.5%
Q3 2016+1.1%+0.1%+11.1%
Q2 2016-6.0%-10.1%-16.4%
Q1 2016+2.9%
Q4 2015-1.7%
Q3 2015-0.9%
Q2 2015+1.0%
Q1 2015-1.1%
Q4 2014-3.8%
Q3 2014-3.9%
Q2 2014+0.1%
Q1 2014-2.8%
Q4 2013+3.9%
Q3 2013-3.0%
Q2 2013-2.9%
Q1 2013+9.4%
Q4 2012-1.1%
Q3 2012+1.4%
Q2 2012-1.1%
Q1 2012-4.9%
Q4 2011+0.3%
Q3 2011+0.8%
Q2 2011-0.2%
Q1 2011+2.9%
Q4 2010+2.4%
Q3 2010-0.4%
Q2 2010+3.3%
Q1 2009+1.1%
Q1 2010+0.3%
Q4 2009-0.1%
Q3 2009+0.1%
Q3 2008+0.1%
Q2 2008+4.6%
Q4 2008+4.6%
Q2 2009+4.6%
Q4 2007+4.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro